Fabio Pacelli currently serves as Head of the Complex Operational Unit of Peritoneum and Retroperitoneum Surgery at Policlinico Gemelli and Associate Professor of General Surgery at Università Cattolica del Sacro Cuore. He earned his Degree in Medicine and Surgery from Università Cattolica del Sacro Cuore in 1985 and obtained his Specialization in General Surgery from Sapienza University of Rome in 1990. He worked as Director of Oncology‑related surgical units at Fondazione di Ricerca e Cura “Giovanni Paolo II” (2010–2016) and held successive director positions at Policlinico Gemelli (2017–present). His work in digestive oncological surgery has resulted in over 200 scientific publications; he recently led multiple Italian multicenter clinical research projects and serves as a lecturer for medical students at Università Cattolica del Sacro Cuore. His research interests mainly include: HIPEC/PIPAC for peritoneal carcinomatosis, gastric and colorectal cancer, retroperitoneal sarcomas, GIST, and neoadjuvant radio‑chemotherapy in surgical oncology.
Fabio Pacelli currently serves as Head of the Complex Operational Unit of Peritoneum and Retroperitoneum Surgery at Policlinico Gemelli and Associate Professor of General Surgery at Università Cattolica del Sacro Cuore. He earned his Degree in Medicine and Surgery from Università Cattolica del Sacro Cuore in 1985 and obtained his Specialization in General Surgery from Sapienza University of Rome in 1990. He worked as Director of Oncology‑related surgical units at Fondazione di Ricerca e Cura “Giovanni Paolo II” (2010–2016) and held successive director positions at Policlinico Gemelli (2017–present). His work in digestive oncological surgery has resulted in over 200 scientific publications; he recently led multiple Italian multicenter clinical research projects and serves as a lecturer for medical students at Università Cattolica del Sacro Cuore. His research interests mainly include: HIPEC/PIPAC for peritoneal carcinomatosis, gastric and colorectal cancer, retroperitoneal sarcomas, GIST, and neoadjuvant radio‑chemotherapy in surgical oncology.